71 related articles for article (PubMed ID: 3683923)
21. [Anti thyroglobulin antibodies in the follow up of patients with differentiated thyroid cancer: residual or relapsing disease markers?].
Quevedo I; Campino C; Rodríguez Portales JA; Arteaga E; López JM; Campusano C; González G; Fardella C; Slater J; Valdivia L; Poggi H; Foradori A; Velasco S
Rev Med Chil; 2002 Feb; 130(2):167-72. PubMed ID: 11974529
[TBL] [Abstract][Full Text] [Related]
22. Gastrointestinal sarcoma (GIST)--a review of surgical management.
Lehnert T
Ann Chir Gynaecol; 1998; 87(4):297-305. PubMed ID: 9891770
[No Abstract] [Full Text] [Related]
23. Renin in Wilms' tumor: prorenin as an indicator.
Elder JS
J Urol; 1995 Jul; 154(1):325-6. PubMed ID: 7776451
[No Abstract] [Full Text] [Related]
24. Evaluation of gastrointestinal stromal tumors for recurrence rates and patterns of long-term follow-up.
Samiian L; Weaver M; Velanovich V
Am Surg; 2004 Mar; 70(3):187-91; discussion 191-2. PubMed ID: 15055839
[TBL] [Abstract][Full Text] [Related]
25. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence.
Lai IR; Lee WJ; Huang MT; Lin HH
Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226
[TBL] [Abstract][Full Text] [Related]
26. Follow-up of patients treated by cytoreduction and chemotherapy for peritoneal carcinomatosis of colorectal origin.
Verwaal VJ; Zoetmulder FA
Eur J Surg Oncol; 2004 Apr; 30(3):280-5. PubMed ID: 15028309
[TBL] [Abstract][Full Text] [Related]
27. Benign positive margins after radical prostatectomy means a poor prognosis--con.
Rubin MA; Montie JE
Urology; 2005 Feb; 65(2):221-3. PubMed ID: 15708026
[No Abstract] [Full Text] [Related]
28. [Special problems of gastrointestinal soft tissue sarcomas].
Lehnert T
Chirurg; 1993 Jul; 64(7):535-43. PubMed ID: 8375203
[No Abstract] [Full Text] [Related]
29. Endoluminal resection for sessile neoplasia in the GI tract is associated with a low recurrence rate and a high 5-year survival rate.
Wang AY; Ahmad NA; Zaidman JS; Brensinger CM; Lewis JD; Long WB; Kochman ML; Ginsberg GG
Gastrointest Endosc; 2008 Jul; 68(1):160-9. PubMed ID: 18577483
[TBL] [Abstract][Full Text] [Related]
30. [The value of PSA follow-up in recurrent prostate carcinoma after radical prostatovesiculectomy].
Trinkler F; Hauri D
Helv Chir Acta; 1994 Dec; 60(6):1081-5. PubMed ID: 7533147
[TBL] [Abstract][Full Text] [Related]
31. Circulating cancer cells: could they be used in the clinic as recurrence markers for gastric and colorectal cancer?
Hanisch E; Hottenrott C; Roukos DH
Ann Surg Oncol; 2009 Mar; 16(3):778-9; author reply 780-2. PubMed ID: 19116754
[No Abstract] [Full Text] [Related]
32. Detection of human mammaglobin mRNA in serial peripheral blood samples from patients with non-metastatic breast cancer is not predictive of disease recurrence.
Marques AR; Teixeira E; Diamond J; Correia H; Santos S; Neto L; Ribeiro M; Miranda A; Passos-Coelho JL
Breast Cancer Res Treat; 2009 Mar; 114(2):223-32. PubMed ID: 18409061
[TBL] [Abstract][Full Text] [Related]
33. [After-care of colorectal carcinoma--value of tumor markers].
Köhne CH; Benter T
Internist (Berl); 1997 Apr; 38(4):363-5. PubMed ID: 9213578
[No Abstract] [Full Text] [Related]
34. [Rising Prostate Specific Antigen following treatment with curative intention].
Jakobsen H; Pedersen KV
Ugeskr Laeger; 2007 May; 169(20):1907-9. PubMed ID: 17553369
[TBL] [Abstract][Full Text] [Related]
35. Editorial comment on: Predictive value of the differential expression of the urokinase plasminogen activation axis in radical prostatectomy patients.
Berney DM
Eur Urol; 2009 May; 55(5):1134. PubMed ID: 18585844
[No Abstract] [Full Text] [Related]
36. Defining recurrence after radiation for prostate cancer.
Kuban DA; Thames HD; Shipley WU
J Urol; 2005 Jun; 173(6):1871-8. PubMed ID: 15879766
[TBL] [Abstract][Full Text] [Related]
37. Pretreatment serum level of HER2/nue as a prognostic factor in metastatic prostate cancer patients about to undergo endocrine therapy.
Okegawa T; Kinjo M; Nutahara K; Higashihara E
Int J Urol; 2006 Sep; 13(9):1197-201. PubMed ID: 16984552
[TBL] [Abstract][Full Text] [Related]
38. Predictive value of the differential expression of the urokinase plasminogen activation axis in radical prostatectomy patients.
Gupta A; Lotan Y; Ashfaq R; Roehrborn CG; Raj GV; Aragaki CC; Montorsi F; Shariat SF
Eur Urol; 2009 May; 55(5):1124-33. PubMed ID: 18585843
[TBL] [Abstract][Full Text] [Related]
39. Carcinoembryonic antigen, biomarker discovery, and trial design.
Yeatman TJ
Ann Surg Oncol; 2006 May; 13(5):600-1. PubMed ID: 16538403
[No Abstract] [Full Text] [Related]
40. Serum immunosuppressive acidic protein doubling time as a prognostic factor for recurrent renal cell carcinoma after nephrectomy.
Araki K; Igarashi T; Tobe T; Mizoguchi K; Suzuki H; Furuya Y; Ichikawa T; Nakatsu HO; Ito H
Urology; 2006 Dec; 68(6):1178-82. PubMed ID: 17141843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
